Skip to main content
. 2022 Sep 16;12:912490. doi: 10.3389/fonc.2022.912490

Figure 4.

Figure 4

Local prostate lesion imaging including involved lymph nodes and pancreatic lesion before and after the administration of pembrolizumab. Contrast-enhanced computed tomography examination: (A) before the administration of pembrolizumab and (B) 5 months after the administration of pembrolizumab. There was complete remission of each lesion (yellow arrowheads).